[1]
S. B. Hiremath and S. D. Lokikere, “Carvedilol versus beta-1 blockers as anti-hypertensive drugs in type-2 diabetes mellitus and pre-diabetic patients with features of metabolic syndrome: a meta-analysis”, Int J Basic Clin Pharmacol, vol. 5, no. 4, pp. 1380–1388, Jan. 2017.